Literature DB >> 16202581

Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.

Helen L Birch1, George M Buckley, Natasha Davies, Hazel J Dyke, Elizabeth J Frost, Philip J Gilbert, Duncan R Hannah, Alan F Haughan, Michael J Madigan, Trevor Morgan, William R Pitt, Andrew J Ratcliffe, Nicholas C Ray, Marianna D Richard, Andrew Sharpe, Alicia J Taylor, Justine M Whitworth, Sophie C Williams.   

Abstract

The synthesis and biological activity of a novel series of 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones are described. Some of these compounds were found to be potent inhibitors of inosine 5'-monophosphate dehydrogenase type II (IMPDH II).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202581     DOI: 10.1016/j.bmcl.2005.06.108

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 2.  2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design.

Authors:  Mariateresa Badolato; Francesca Aiello; Nouri Neamati
Journal:  RSC Adv       Date:  2018-06-07       Impact factor: 4.036

3.  Quinazolin-4-one coupled with pyrrolidin-2-iminium alkaloids from marine-derived fungus Penicillium aurantiogriseum.

Authors:  Fuhang Song; Biao Ren; Ke Yu; Caixia Chen; Hui Guo; Na Yang; Hong Gao; Xueting Liu; Mei Liu; Yaojun Tong; Huanqin Dai; Hua Bai; Jidong Wang; Lixin Zhang
Journal:  Mar Drugs       Date:  2012-06-07       Impact factor: 6.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.